Principal Investigators
ORYZON GENOMICS, S.A.
Institution
ORYZON GENOMICS, S.A.
Contact information of lead PI
Country
Spain
Title of project or programme
THERAPEUTIC USE OF EPIGENETIC MODULATORS IN ONCOLOGICAL AND NEURODEGENERATIVE DISEASE
Source of funding information
CDTI
Total sum awarded (Euro)
920,002
Start date of award
01/10/2015
Total duration of award in years
2.8
The project/programme is most relevant to:
Alzheimer's disease & other dementias
Keywords
Research Abstract
Lay Summary
Further information available at:
Types: Investments > €500k
Member States: Spain
Diseases: Alzheimer's disease & other dementias
Years: 2016
Database Categories: N/A
Database Tags: N/A